SCHEMBL9968569

SCHEMBL9968569

CCC(=O)c1cc(S(=O)(=O)NCc2ccc(O)c(O)c2)ccc1OC(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.44
LMNA P02545 2/20 0.44
RAB9A P51151 1/20 0.44
KDM4E B2RXH2 7/20 0.40
ALDH1A1 P00352 4/20 0.40
KMT2A Q03164 4/20 0.40
POLB P06746 2/20 0.40
MEN1 O00255 2/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
HPGD P15428 1/20 0.40
TUBB P07437 1/20 0.39
NAMPT P43490 1/20 0.39
MAPT P10636 2/20 0.38
HTT P42858 1/20 0.38
TP53 P04637 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9968581 0.90 KDM4E (0.43) MAPK1LMNARAB9AKDM4EALDH1A1
SCHEMBL9941253 0.84 KMT2A (0.59) LMNAALDH1A1KMT2APOLBMEN1
SCHEMBL9968024 0.83 SLC6A2 (0.45) RAB9AKMT2APOLBMEN1SLC6A2
SCHEMBL9968585 0.82 PKM (0.50) ALDH1A1KMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL9968618 0.82 KMT2A (0.47) MAPK1LMNARAB9AKDM4EALDH1A1
SCHEMBL9968023 0.81 SLC6A2 (0.41) MAPK1RAB9AALDH1A1KMT2APOLB
SCHEMBL9968571 0.79 SLC22A12 (0.43) SLC6A2SLC6A4SLC6A3NAMPT
SCHEMBL9968477 0.78 ALDH1A1 (0.43) MAPK1LMNARAB9AKDM4EALDH1A1
SCHEMBL9941527 0.76 TSHR (0.60) LMNAALDH1A1KMT2APOLBMEN1
SCHEMBL15609395 0.73 MAPT (0.60) LMNAALDH1A1KMT2APOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012082862-A2 ANDROGEN RECEPTOR INHIBITORS AND METHODS OF USE THEREOF BETH ISRAEL DEACONESS MEDICAL CENTER (US) 2012-06-21 WO disclosed